[1] |
Guo BW, Pan T, Chen HB, et al. Clinicopathologic Characteristics and Prognosis Analysis of Marjolin′s Ulcer in 40 Cases[J]. Curr Med Sci, 2018, 38(6): 1038-1044.
|
[2] |
张家平,江旭品. 瘢痕癌性溃疡诊断与治疗专家共识(2020年版)[J/CD]. 中华损伤与修复杂志(电子版), 2020, 15(4): 264-267.
|
[3] |
Kanth AM, Heiman AJ, Nair L, et al. Current Trends in Management of Marjolin′s Ulcer: A Systematic Review[J]. J Burn Care Res, 2021, 42(2): 144-151.
|
[4] |
Das KK, Chakaraborty A, Rahman A, et al. Incidences of malignancy in chronic burn scar ulcers: experience from Bangladesh[J]. Burns, 2015, 41(6): 1315-1321.
|
[5] |
Kim JM, Su WP, Kurtin PJ, et al. Marjolin′s ulcer: immunohistochemical study of 17 cases and comparison with common squamous cell carcinoma and basal cell carcinoma[J]. J Cutan Pathol, 1992, 19(4): 278-285.
|
[6] |
Oruç M, Kankaya Y, Sungur N, et al. Clinicopathological evaluation of Marjolin ulcers over two decades[J]. Kaohsiung J Med Sci, 2017, 33(7): 327-333.
|
[7] |
Alvarez Rio A, Roca Mas JO, Navarro Sanchez D, et al. Aggressive Acute Marjolin′s Ulcer Arising in a Burn Scar[J]. Case Rep Dermatol Med, 2022, 2022: 8329050.
|
[8] |
Chiriac AE, Betiu M, Brzezinski P, et al. Malignant Degeneration of Scars[J]. Cancer Manag Res, 2020, 12: 10297-10302.
|
[9] |
Kawaguchi M, Kato H, Tomita H, et al. Magnetic Resonance Imaging Findings Differentiating Cutaneous Basal Cell Carcinoma from Squamous Cell Carcinoma in the Head and Neck Region[J]. Korean J Radiol, 2020, 21(3): 325-331.
|
[10] |
Abdi MA, Yan M, Hanna TP. Systematic Review of Modern Case Series of Squamous Cell Cancer Arising in a Chronic Ulcer (Marjolin′s Ulcer) of the Skin[J]. JCO Glob Oncol, 2020, 6: 809-818.
|
[11] |
Saaiq M, Ashraf B. Marjolin′s ulcers in the post-burned lesions and scars[J]. World J Clin Cases, 2014, 2(10): 507-514.
|
[12] |
Copcu E. Marjolin′s ulcer: a preventable complication of burns?[J]. Plast Reconstr Surg, 2009, 124(1): 156e-164e.
|
[13] |
Boykin JV, Eriksson E, Pittman RN. In vivo microcirculation of a scald burn and the progression of postburn dermal ischemia[J]. Plast Reconstr Surg, 1980, 66(2): 191-198.
|
[14] |
Prasanna M, Mishra P, Thomas C. Delayed primary closure of the burn wounds[J]. Burns, 2004, 30(2): 169-175.
|
[15] |
Kowal-Vern A, Criswell BK. Burn scar neoplasms: a literature review and statistical analysis[J]. Burns, 2005, 31(4): 403-413.
|
[16] |
Zuo KJ, Tredget EE. Multiple Marjolin′s ulcers arising from irradiated post-burn hypertrophic scars: a case report[J]. Burns, 2014, 40(4): e21-25.
|
[17] |
Eliassen A, Vandy F, McHugh J, et al. Marjolin′s ulcer in a patient with chronic venous stasis[J]. Ann Vasc Surg, 2013, 27(8): 1182.e5-8.
|
[18] |
Smith J, Mello LF, Nogueira Neto NC, et al. Malignancy in chronic ulcers and scars of the leg (Marjolin′s ulcer): a study of 21 patients[J]. Skeletal Radiol, 2001, 30(6): 331-337.
|
[19] |
Conlon C, Pupa L, Reece EM, et al. When Benign Becomes Cancer: Malignant Degeneration of Chronic Inflammation[J]. Semin Plast Surg, 2021, 35(3): 159-163.
|
[20] |
秦国强,丁明华. MEBO联合NPWT、自体微粒皮种植技术在瘢痕性压疮治疗中的创新应用[C]//第15届全国烧伤创疡学术会议论文汇编,2018: 339-343.
|
[21] |
Furtado C, Datta P, Zeitoun R. Radiological appearances of metastatic Marjolin ulcer in a chronic pressure sore: a case report and literature review[J]. Radiol Case Rep, 2022, 17(10): 3907-3910.
|
[22] |
Allepot K, Curings P, Viard R, et al. Diagnostic pitfall: Early arising, multiple and recurrent Marjolin′s ulcer. About 8 patients (16 tumors) and literature review[J]. Ann Chir Plast Esthet, 2021, 66(2): 151-158.
|
[23] |
Ghadiri SJ, Kloczko E, Flohr C. Topical treatments in the management of keloids and hypertrophic scars: a critically appraised topic[J]. Br J Dermatol, 2022, 187(6): 855-856.
|
[24] |
Nielsen RM, Andersen F, Salskov-Iversen ML. Squamous cell carcinoma in ulcer after bacille Calmette-Guérin vaccination[J]. Ugeskr Laeger, 2014, 176(42): V01140059.
|
[25] |
Kluger N, Dissard C. Basal cell carcinoma in a smallpox vaccination scar[J]. Presse Med, 2014, 43(3): 332-333.
|
[26] |
Bazaliński D, Przybek-Mita J, Barańska B, et al. Marjolin′s ulcer in chronic wounds - review of available literature[J]. Contemp Oncol (Pozn), 2017, 21(3): 197-202.
|
[27] |
Czarnecki D, Nicholson I, Tait B, et al. HLA DR4 is associated with the development of multiple basal cell carcinomas and malignant melanoma[J]. Dermatology, 1993, 187(1): 16-18.
|
[28] |
Harland DL, Robinson WA, Franklin WA. Deletion of the p53 gene in a patient with aggressive burn scar carcinoma[J]. J Trauma, 1997, 42(1): 104-107.
|
[29] |
Lee SH, Shin MS, Kim HS, et al. Somatic mutations of Fas (Apo-1/CD95) gene in cutaneous squamous cell carcinoma arising from a burn scar[J]. J Invest Dermatol, 2000, 114(1): 122-126.
|
[30] |
Wang L, Hou S, Li J, et al. Circular RNA circ-LARP1B contributes to cutaneous squamous cell carcinoma progression by targeting microRNA-515-5p/TPX2 microtubule nucleation factor axis[J]. Bioengineered, 2022, 13(1): 1209-1223.
|
[31] |
Chen J, Hou SF, Tang FJ, et al. HOTAIR/Sp1/miR-199a critically regulates cancer stemness and malignant progression of cutaneous squamous cell carcinoma[J]. Oncogene, 2022, 41(1): 99-111.
|
[32] |
Sinha S, Su S, Workentine M, et al. Transcriptional Analysis Reveals Evidence of Chronically Impeded ECM Turnover and Epithelium-to-Mesenchyme Transition in Scar Tissue Giving Rise to Marjolin′s Ulcer[J]. J Burn Care Res, 2017, 38(1): e14-e22.
|
[33] |
Foster DS, Jones RE, Ransom RC, et al. The evolving relationship of wound healing and tumor stroma[J]. JCI Insight, 2018, 3(18): e99911.
|
[34] |
Lu P, Weaver VM, Werb Z. The extracellular matrix: a dynamic niche in cancer progression[J]. J Cell Biol, 2012, 196(4): 395-406.
|
[35] |
Alhysoni KA, Bukhari SM, Hajjaj MF. Acute Marjolin′s Ulcer in a Postauricular Scar after Mastoidectomy[J]. Case Rep Otolaryngol, 2016, 2016: 2046954.
|
[36] |
Burusapat C, Wanichjaroen N, Wongprakob N, et al. Characteristics of Marjolin′s Ulcers in 21st Century: A Retrospective Study, Systematic Review, and Surgical Guideline Recommendation[J]. J Burn Care Res, 2021, 42(2): 152-166.
|
[37] |
Sadegh Fazeli M, Lebaschi AH, Hajirostam M, et al. Marjolin′s ulcer: clinical and pathologic features of 83 cases and review of literature[J]. Med J Islam Repub Iran, 2013, 27(4): 215-224.
|
[38] |
牛大伟,韩志新,李振超,等. 31例烧伤后瘢痕癌患者的临床治疗分析[J]. 中国烧伤创疡杂志,2021, 33(4): 291-295.
|
[39] |
Pratt DV, Pelton RW, Patel BC, et al. Burn scar malignancies of the eyelids[J]. Ophthalmic Plast Reconstr Surg, 2000, 16(6): 432-437.
|
[40] |
Tavares E, Martinho G, Dores JA, et al. Marjolin′s ulcer associated with ulceration and chronic osteomyelitis[J]. An Bras Dermatol, 2011, 86(2): 366-369.
|
[41] |
Sánchez-García A, Alonso-Carpio M, Trapero A, et al. Atypical Presentation of a Marjolin Ulcer After a Burn: A Case Report[J]. Plast Surg Nurs, 2020, 40(4): 195-196.
|
[42] |
Bozkurt M, Kapi E, Kuvat SV, et al. Current concepts in the management of Marjolin′s ulcers: outcomes from a standardized treatment protocol in 16 cases[J]. J Burn Care Res, 2010, 31(5): 776-780.
|
[43] |
Shen R, Zhang J, Zhang F, et al. Clinical characteristics and therapeutic analysis of 51 patients with Marjolin′s ulcers[J]. Exp Ther Med, 2015, 10(4): 1364-1374.
|
[44] |
Brantsch KD, Meisner C, Sch?nfisch B, et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study[J]. Lancet Oncol, 2008, 9(8): 713-720.
|
[45] |
Motley R, Arron S. Mohs micrographic surgery for cutaneous squamous cell carcinoma[J]. Br J Dermatol, 2019, 181(2): 233-234.
|
[46] |
Karasoy Yesilada A, Zeynep Sevim K, Özgur Sucu D, et al. Marjolin ulcer: clinical experience with 34 patients over 15 years[J]. J Cutan Med Surg, 2013, 17(6): 404-409.
|
[47] |
Yoo JJ, Kim HS, Kim JH, et al. Clinical features and treatment outcomes of skin cancer arising from burn scar: a single-institution experience[J]. Tumori, 2014, 100(1): 26-30.
|
[48] |
Pala M, Novakova P, Pechacova Z, et al. Long-term results of radio(chemo)therapy in metastatic carcinoma to cervical lymph nodes from an unknown primary. Adult Comorbidity Evaluation 27 score as a predictor of survival[J]. Strahlenther Onkol, 2023, 199(2): 149-159.
|
[49] |
Marcus J, Glassberg E, Dimino-Emme L, et al. Photodynamic therapy for the treatment of squamous cell carcinoma using benzoporphyrin derivative[J]. J Dermatol Surg Oncol, 1994, 20(6): 375-382.
|
[50] |
Shi L, Liu P, Wu J, et al. The effectiveness and safety of X-PDT for cutaneous squamous cell carcinoma and melanoma[J]. Nanomedicine (Lond), 2019, 14(15): 2027-2043.
|
[51] |
Keyal U, Bhatta AK, Zhang G, et al. Present and future perspectives of photodynamic therapy for cutaneous squamous cell carcinoma[J]. J Am Acad Dermatol, 2019, 80(3): 765-773.
|
[52] |
Keyal U, Luo Q, Bhatta AK, et al. Zinc pthalocyanine-loaded chitosan/mPEG-PLA nanoparticles-mediated photodynamic therapy for the treatment of cutaneous squamous cell carcinoma[J]. J Biophotonics, 2018, 11(11): e201800114.
|
[53] |
Almeida Gonçalves JC. Advanced cancer of the extremities treated by cryosurgery[J]. G Ital Dermatol Venereol, 2011, 146(4): 249-255.
|
[54] |
Lee CN, Pan SC, Lee JY, et al. Successful treatment of cutaneous squamous cell carcinoma with intralesional cryosurgery: Case report[J]. Medicine (Baltimore), 2016, 95(39): e4991.
|
[55] |
Xu C, Zhuo Y, Liu Y, et al. Itraconazole Inhibits the Growth of Cutaneous Squamous Cell Carcinoma by Targeting HMGCS1/ACSL4 Axis[J]. Front Pharmacol, 2022, 13: 828983.
|
[56] |
Zhang Z, Deng X. circ_0001821 Contributes to the Development of Cutaneous Squamous Cell Carcinoma by Regulating MicroRNA-148a-3p/EGFR Axis and Activating Phosphatidylinositol 3-Kinase/Akt Pathway[J]. Mol Cell Biol, 2022, 42(3): e0008921.
|
[57] |
Liang D, Zhang Z. MicroRNA-27b-3p inhibits the proliferation and invasion of cutaneous squamous cell carcinoma by targeting EGFR and MMP-13[J]. Oncol Lett, 2021, 22(4): 729.
|